XGN — EXAGEN INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1274737 ·
Last close
$8.48
Market Cap
$205.43M
52W High
$12.23
52W Low
$2.59
ADV30
291,819
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 19,941,000 | 12,217,000 | -1,722,000 | -3,196,000 | 51,935,000 | 24,588,000 | 39,719,000 |
| Mar 2026 | 17,306,000 | 10,205,000 | -3,414,000 | -3,967,000 | 51,957,000 | 21,513,000 | 37,525,000 |
| Dec 2025 | 16,631,000 | 9,206,000 | -4,975,000 | -4,673,000 | 58,022,000 | 32,220,000 | 40,573,000 |
| Sep 2025 | 17,244,000 | 10,075,000 | -3,100,000 | -7,087,000 | 62,823,000 | 35,652,000 | 44,685,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,498,000
Investing CF
$-1,081,000
Financing CF
$2,134,000
CapEx
$-1,090,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.81
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-321,445,000
Inventory
—
Receivables
$12,407,000
ST Investments
—
EBIT TTM
$-13,756,000
Pretax Income TTM
$-18,873,000
Interest Exp TTM
$5,117,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$71,122,000
EBITDA
$-10,772,000
Free Cash Flow
$-1,557,000
Enterprise Value
$173,372,128
Total Cash
$24,588,000
Total Debt
$27,656,000
Shares Out
24,225,339
Trailing EPS
$-0.82
Book Value
$0.51
ROE
-113.8%
ROA
-14.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 66,575,000 | -14,070,000 | -19,951,000 | 58,022,000 | 40,573,000 | 17,449,000 | -13,625,000 |
| Dec 2024 | 55,641,000 | -13,636,000 | -15,115,000 | 44,689,000 | 35,149,000 | 9,540,000 | -13,279,000 |
| Dec 2023 | 52,548,000 | -22,837,000 | -23,689,000 | 56,944,000 | 34,250,000 | 22,694,000 | -14,462,000 |
| Dec 2022 | 45,563,000 | -40,545,000 | -47,387,000 | 86,221,000 | 43,761,000 | 42,460,000 | -32,144,000 |
TTM Snapshot
Revenues TTM
$56,147,000
NetIncome TTM
$-22,291,000
OpCashFlow TTM
$0
Assets (Latest)
$58,022,000
Forward EPS
$-0.47
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $8.48 · call volume: 113 · put volume: 3
Expected Move to 2026-10-16:
±$1.85
(21.82%) —
implied range
$6.63 –
$10.33
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BNR | Burning Rock Biotech Ltd | $155.39M | $17.63 | — |
| AUNA | AUNA S.A. | $151.30M | $5.02 | — |
| LFMD | LifeMD, Inc. | $141.23M | $2.93 | — |
| AIRS | Airsculpt Technologies, Inc. | $135.54M | $1.88 | — |
| BDSX | BIODESIX INC | $320.97M | $30.42 | — |
News headlines (Yahoo Finance, 1h cache)
Exagen (XGN) Q2 2026 Earnings Call Transcript
2026-08-11 17:31 · Yahoo
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
2026-08-06 04:32 · Yahoo
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
2026-08-04 15:28 · Yahoo
Exagen Inc. Reports Second Quarter 2026 Financial Results
2026-08-04 12:00 · Yahoo
Exagen to Announce Second Quarter Financial Results on August 4, 2026
2026-07-21 13:00 · Yahoo
Exagen (XGN) Stock Draws Fresh Price Target Split After Analysts Trim Targets
2026-06-19 04:33 · Yahoo
How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%
2026-05-28 13:55 · Yahoo
Exagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
2026-05-12 07:02 · Yahoo
Exagen Inc. Q2 2026 Earnings Call Summary
2026-08-04 21:23 · Yahoo
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability
2026-08-04 21:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.